Healthcare-associated pneumonia: Principles and emerging concepts on management

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 18, 2007, Pages 3117-3131

  Chroneou, Alexandra ^a   Zias, Nikolaos ^a   Beamis Jr , John F ^a,b   Craven, Donald E ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotic; antimicrobial resistance; ATS IDSA HAP; HCAP guideline; healthcare associated pneumonia; multi drug resistant bacteria; nursing home; VAP; ventilator associated pneumonia

Indexed keywords

ANTIINFECTIVE AGENT;

AGED; BACTERIAL PNEUMONIA; CROSS INFECTION; HOSPITALIZATION; HUMAN; MICROBIOLOGY; MULTIDRUG RESISTANCE; NURSING HOME; PRACTICE GUIDELINE; REVIEW;

AGED; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALIZATION; HUMANS; NURSING HOMES; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC;

EID: 40949092806     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.8.18.3117     Document Type: Review

References (110)

1. AMERICAN THORACIC SOCIETY AND INFECTIOUS DISEASES SOCIETY OF AMERICA GUIDELINE COMITEE: Guidelines for the management of adults with hospital-acquired, ventilatory-associated, and health care-associated pneumonia. Am. J. Respir. Care Med. (2005) 171:388-416.
2. CRAVEN DE, PALLADINO R, MCQUILLEN DP: Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect. Dis. Clin. North Am. (2004) 18(4):939-962.
3. TABLAN OC, ANDERSON LJ, BESSER R, BRIDGES C, HAJJEH R: Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the healthcare infection control practices advisory committee. MMWR Recomm. Rep. (2004) 53(RR-3):1-36.
4. KOLLEF MH: Diagnosis of ventilator-associated pneumonia. N. Engl. J. Med. (2006) 355(25):2691-2693.
5. POP-VICAS AE, D'AGATA EM: The rising infl ux of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clin. Infect. Dis. (2005) 40(12): 1792-1798.
6. IBRAHIM EH, WARD S, SHERMAN G et al : Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit. Care Med. (2001) 29(6): 1109-1115.
7. RELLO J, VALLES J: Mortality as an outcome in hospital-acquired pneumonia. Infect. Control. Hosp. Epidemiol. (1998) 19(10):795-797.
8. STEVENSON KB: Regional data set of infection rates for long-term care facilities: description of a valuable benchmarking tool. Am. J. Infect. Control. (1999) 27(1):20-26.
9. MUDER RR: Pneumonia in residents of long-term care facilities: epidemiology etiology, management, and prevention. Am. J. Med. (1998) 105(4):319-330.
10. KOLLEF MH, SHORRA, TABAK YP et al : Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest (2005) 128(6):3854-3862.
11. FRIEDMAN ND, KAYE KS, STOUT JE et al : Health care-associated bloodstream infections in adults: a reason to change the accepted defi nition of community-acquired infections. Ann. Intern. Med. (2002) 137(10):791-797.
12. NAIMITS, LEDELL KH, COMO-SABETTI K et al.: Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA (2003) 290(22): 2976-2984.
13. CARRATALAJ, MYKIETIUKA, FERNANDEZ-SABE N: Health care-associated pneumonias requiring hospital admission. Arch. Intern. Med. (2007) 167 :1393-1399.
14. EL SOLH AA, PIETRANTONI C, BHAT A, BHORA M, BERBARY E: Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin. Infect. Dis. (2004) 39(4):474-480.
15. MUDER RR, BRENNEN C, WAGENER MM et al.: Methicillin-resistant staphylococcal colonization and infection in a long-term care facility Ann. Intern. Med. (1991) 114(2): 107-112.
16. NICOLLE LE, MCLEOD J, MCINTYRE M, MACDONELL JA: Signifi cance of pharyngeal colonization with aerobic gram-negative bacilli in elderly institutionalized men. Age Ageing (1986) 15(1):47-52.
17. VALENTIWM, TRUDELL RG, BENTLEY DW: Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged. N. Engl. J. Med. (1978) 298(20): 1108-1111.
18. MURRAY PR, WASHINGTON JA: Microscopic and baceriologic analysis of expectorated sputum. Mayo Clin. Proc. (1975) 50(6):339-344.
19. DRINKA PJ, GAUERKE C, VOEKS S et al : Pneumonia in a nursing home. J. Gen. Intern. Med. (1994) 9(11):650-652.
20. MARRIETJ, DURANT H, KWAN C: Nursing home-acquired pneumonia. A case-control study. J. Am. Geriatr. Soc. (1986) 34(10):697-702.
21. PETERSON PK, STEIN D, GUAY DR et al : Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofl oxacin. Am. J. Med. (1988) 85(2):164-171.
22. MARRIE TJ, DURANT H, YATES L: Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev. Infect. Dis. (1989) 11(4):586-599.
23. HIRATA-DULAS CA, STEIN DJ, GUAY DR, GRUNINGER RP, PETERSON PK: A randomized study of ciprofl oxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J. Am. Geriatr. Soc. (1991) 39(10):979-985.
24. ALVAREZ S, SHELL CG, WOOLLEY TW, BERK SL, SMITH JK: Nosocomial infections in long-term facilities. J. Gerontol. (1988) 43(1):M9-M17.
25. GARB JL, BROWN RB, GARB JR, TUTHILL RW: Differences in etiology of pneumonias in nursing home and community patients. JAMA (1978) 240(20):2169-2172.
26. MAGNUSSEN MH, ROBB SS: Nosocomial infections in a long-term care facility. Am. J. Infect. Control (1980) 8(1): 12-17.
27. GAMBERT SR, DUTHIE EH Jr, PRIEFER B, RABINOVITCH RA: Bacterial infections in a hospital-based skilled nursing facility. J. Chronic Dis. (1982) 35(10):781-786.
28. NICOLLE LE, MCINTYRE M, ZACHARIAS H, MACDONELL JA: Twelve-month surveillance of infections in institutionalized elderly men. J. Am. Geriatr. Soc. (1984) 32(7):513-519.
29. SETIA U, SERVENTI I, LORENZ P: Bacteremia in a long-term care facility. Spectrum and mortality. Arch. Intern. Med. (1984) 144(8):1633-1635.
30. FINNEGAN TP, AUSTIN TW, CAPE RD: A 12-month fever surveillance study in a veterans' long-stay institution. J. Am. Geriatr. Soc. (1985) 33(9):590-594.
31. JACOBSON C, STRAUSBAUGH LJ: Incidence and impact of infection in a nursing home care unit. Am. J. Infect. Control. (1990) 18(3):151-159.
32. FANG GD, FINE M, ORLOFF J et al.: New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 69(5):307-316.
33. MUDER RR, BRENNEN C, WAGENER MM, GOETZ AM: Bacteremia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes. Clin. Infect. Dis. (1992) 14(3):647-654.
34. MCDONALD AM, DIETSCHE L, LITSCHE M et al. : A retrospective study of nosocomial pneumonia at a long-term care facility. Am. J. Infect. Control. (1992) 20(5):234-238.
35. PHILLIPS SL, BRANAMAN-PHILLIPS J: The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia. J. Am. Geriatr. Soc. (1993) 41(10):1071-1074.
36. SMITH MA, DUKE WM: A retrospective review of nosocomial infections in an acute rehabilitative and chronic population at a large skilled nursing facility. J. Am. Geriatr. Soc. (1994) 42(1):45-49.
37. LIM WS, MACFARLANE JT: A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur. Respir. J. (2001) 18(2):362-368.
38. EL-SOLH AA, SIKKA P, RAMADAN F, DAVIES J: Etiology of severe pneumonia in the very elderly Am. J. Respir. Crit. Care Med. (2001) 163(3 Part 1):645-651.
39. EL SOLH AA, AKINNUSI ME, PINEDA LA, MANKOWSKI CR: Diagnostic yield of quantitative endotracheal aspirates in patients with severe nursing home-acquired pneumonia. Crit. Care (2007) 11(3):R57.
40. EL-SOLH AA, AQUILINA AT, DHILLON RS et al. : Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am. J. Respir. Crit. Care Med. (2002) 166(8): 1038-1043.
41. LUNA CM, VUJACICH P, NIEDERMAN MS et al. : Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest (1997) 111(3):676-685.
42. MARKOWICZ P, WOLFF M, DJEDAINI K et al.: Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS study group. Am. J. Respir. Crit. Care Med. (2000) 161 (6): 1942-1948.
43. LOEB M, MCGEER A, MCARTHUR M et al. : Surveillance for outbreaks of respiratory tract infections in nursing homes. CMAJ (2000) 162(8): 1133-1137.
44. MAESAKI S, KOHNO S, KOGA H et al.: An outbreak of Legionnaires' pneumonia in a nursing home. Intern. Med. (1992) 31(4):508-512.
45. STOUT JE, BRENNEN C, MUDER RR: Legionnaires' disease in a newly constructed long-term care facility. J. Am. Geriatr. Soc. (2000) 48(12):1589-1592.
46. TROY CJ, PEELING RW, ELLIS AG et al.: Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA (1997) 277(15):1214-1218.
47. FROM THE CENTERS FOR DISEASE CONTROL: Control of infl uenza A outbreaks in nursing homes: amantadine as adjunct to vaccine-1989-1990. JAMA (1992) 267(3):344, 346.
48. PATRIARCA PA, WEBER JA, PARKER RA et al.: Effi cacy of infl uenza vaccine in nursing homes. Reduction in illness and complications during an infl uenza A (H3N2) epidemic. JAMA (1985) 253(8):1136-1139.
49. HART RJ: An outbreak of respiratory syncytial virus infection in an old people's home. J. Infect. (1984) 8(3):259-261.
50. AGIUS G, DINDINAUD G, BIGGAR RJ et al. : An epidemic of respiratory syncytial virus in elderly people: clinical and serological fi ndings. J. Med. Virol. (1990) 30(2):117-127.
51. EL-SOLH AA, PIETRANTONI C, BHAT A et al. : Microbiology of severe aspiration pneumonia in institutionalized elderly. Am. J. Respir. Crit. Care Med. (2003) 167(12):1650-1654.
52. MARIK PE, KAPLAN D: Aspiration pneumonia and dysphagia in the elderly. Chest (2003) 124(1):328-336.
53. VERGHESE A, BERK SL: Bacterial pneumonia in the elderly. Medicine (Baltimore) (1983) 62(5):271-285.
54. KIKUCHI R, WATABE N, KONNO T et al. : High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. (1994) 150(1):251-253.
55. JOHANSON WG, PIERCE AK, SANFORD JP: Changing pharyngeal bacterial fl ora of hospitalized patients. Emergence of gram-negative bacilli. N. Engl. J. Med. (1969) 281(21):1137-1140.
56. MARRIE TJ: Pneumonia in the long-term-care facility. Infect. Control. Hosp. Epidemiol. (2002) 23(3):159-164.
57. PICK N, MCDONALD A, BENNETT N et al.: Pulmonary aspiration in a long-term care setting: clinical and laboratory observations and an analysis of risk factors. J. Am. Geriatr. Soc. (1996) 44(7):763-768.
58. MARIK PE: Aspiration pneumonitis and aspiration pneumonia. N. Engl. J. Med. (2001) 344(9):665-671.
59. KLOMPAS M: Does this patient have ventilator-associated pneumonia? JAMA (2007) 297(14):1583-1593.
60. BENTLEY DW, BRADLEY S, HIGH K et al. : Practice guideline for evaluation of fever and infection in long-term care facilities. Clin. Infect. Dis. (2000) 31(3):640-653.
61. MEDINA-WALPOLE AM, MCCORMICK WC: Provider practice patterns in nursing home-acquired pneumonia. J. Am. Geriatr. Soc. (1998) 46(2):187-192.
62. WEINBERG AD, PALS JK, LEVESQUE PG et al: Dehydration and death during febrile episodes in the nursing home. J. Am. Geriatr. Soc. (1994) 42(9):968-971.
63. MYLOTTE JM, NAUGHTON B, SALUDADES C, MASZAROVICS Z: Validation and application of the pneumonia prognosis index to nursing home residents with pneumonia. J. Am. Geriatr. Soc. (1998) 46(12): 1538-1544.
64. NARAIN JP, LOFGREN JP, WARREN E, STEAD WW: Epidemic tuberculosis in a nursing home: a retrospective cohort study. J. Am. Geriatr. Soc. (1985) 33(4):258-263.
65. JANSSENS JP, KRAUSE KH: Pneumonia in the very old. Lancet Infect. Dis. (2004) 4(2): 112-124.
66. MUSGRAVE T, VERGHESE A: Clinical features of pneumonia in the elderly Semin. Respir. Infect. (1990) 5(4):269-275.
67. CHASTRE J, FAGON JY: Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. (2002) 165(7):867-903.
68. FAGON JY, CHASTRE J, WOLFF M et al. : Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann. Intern. Med. (2000) 132(8):621-630.
69. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N. Engl. J. Med. (2006) 355(25):2619-2630.
70. SOUWEINE B, VEBER B, BEDOS JP et al. : Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit. Care Med. (1998) 26(2):236-244.
71. MANDELL LA, MARRIETJ, GROSSMAN RF, CHOW AW, HYLAND RH: Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian infectious diseases society and the Canadian thoracic society. The Canadian community-acquired pneumonia working group. Clin. Infect. Dis. (2000) 31(2):383-421.
72. MANDELL LA, BARTLETT JG, DOWELL SF et al. : Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. (2003) 37(11): 1405-1433.
73. VANDERKOOI OG, LOW DE, GREEN K, POWIS JE, MCGEER A: Predicting antimicrobial resistance in invasive pneumococcal infections. Clin. Infect. Dis. (2005) 40(9): 1288-1297.
74. DEGELAU J, GUAY D, STRAUB K, LUXENBERG MG: Effectiveness of oral antibiotic treatment in nursing home-acquired pneumonia. J. Am. Geriatr. Soc. (1995) 43(3):245-251.
75. MEEHAN TP, FINE MJ, KRUMHOLZ HM et al : Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA (1997) 278(23): 2080-2084.
76. NAUGHTON BJ, MYLOTTE JM: Treatment guideline for nursing home-acquired pneumonia based on community practice. J. Am. Geriatr. Soc. (2000) 48(1):82-88.
77. FRIED TR, GILLICK MR, LIPSITZ LA: Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia. J. Gen. Intern. Med. (1995) 10(5):246-250.
78. HUTT E, KRAMER AM: Evidence-based guidelines for management of nursing home-acquired pneumonia. J. Fam. Pract. (2002) 51(8):709-716.
79. HUTT E, FREDERICKSON E, ECORD M, KRAMER AM: Associations among processes and outcomes of care for Medicare nursing home residents with acute heart failure. J. Am. Med. Dir. Assoc. (2003) 4(4): 195-199.
80. NAUGHTON BJ, MYLOTTE JM, TAYARA A: Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortality. J. Am. Geriatr. Soc. (2000) 48(10): 1292-1299.
81. KOLLEF MH, SHERMAN G, WARD S, FRASER VJ: Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 115(2):462-474.
82. CHASTRE J, WOLFF M, FAGON JY et al : Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA (2003) 290(19):2588-2598.
83. FINK MP, SNYDMAN DR, NIEDERMAN MS et al.: Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofl oxacin with imipenem-cilastatin. The severe pneumonia study group. Antimicrob. Agents Chemother. (1994) 38(3):547-557.
84. COMETTAA, BAUMGARTNERJD, LEW D et al. : Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob. Agents Chemother. (1994) 38(6): 1309-1313.
85. HILF M, YU VL, SHARP J et al.: Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am. J. Med. (1989) 87(5):540-546.
86. WOOD GC, HANES SD, CROCE MA, FABIAN TC, BOUCHER BA: Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin. Infect. Dis. (2002) 34(11):1425-1430.
87. HAMER DH: Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am. J. Respir. Crit. Care Med. (2000) 162(1):328-330.
88. GARNACHO-MONTERO J, ORTIZ-LEYBA C, JIMENEZ-JIMENEZ FJ et al.: Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin. Infect. Dis. (2003) 36(9):1111-1118.
89. PATERSON DL, KO WC, VON GOTTBERG A et al.: Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J. Clin. Microbiol. (2001) 39(6):2206-2212.
90. CHOW JW, FINE MJ, SHLAES DM et al. : Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. (1991) 115(8):585-590.
91. QUEENAN AM, FOLENO B, GOWNLEY C, WIRA E, BUSH K: Effects of inoculum and β-lactamase activity in AmpC-and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J. Clin. Microbiol. (2004) 42(1):269-275.
92. PATERSON DL, KOWC, VON GOTTBERG A et al.: Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin. Infect. Dis. (2004) 39(1):31-37.
93. MOISE PA, FORREST A, BHAVNANI SM, BIRMINGHAM MC, SCHENTAG JJ: Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus. Am. J. Health Syst. Pharm. (2000) 57 (Suppl. 2):S4-S9.
94. FAGON J, PATRICK H, HAAS DW et al. : Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/ dalfopristin versus vancomycin. Nosocomial pneumonia group. Am. J. Respir. Crit. Care Med. (2000) 161(3 Part 1):753-762.
95. MALANGONI MA, CRAFTON R, MOCEK FC: Pneumonia in the surgical intensive care unit: factors determining successful outcome. Am. J. Surg. (1994) 167(2):250-255.
96. LEVINE DP, FROMM BS, REDDY BR: Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. (1991) 115(9):674-680.
97. WYSOCKI M,THOMAS F, WOLFF MA et al. : Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections. J. Antimicrob. Chemother. (1995) 35(2):352-354.
98. WUNDERINK RG, RELLO J, CAMMARATA SK, CROOS-DABRERA RV, KOLLEF MH: Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest (2003) 124(5):1789-1797.
99. RUBINSTEIN E, CAMMARATA S, OLIPHANT T, WUNDERINK R: Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin. Infect. Dis. (2001) 32(3):402-412.
100. CONTE JE Jr, GOLDEN JA, KIPPS J, ZURLINDEN E: Intrapulmonary pharmacokinetics of linezolid. Antimicrob. Agents Chemother. (2002) 46(5):1475-1480.
101. GOETZ MB, SAYERS J: Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. J. Antimicrob. Chemother. (1993) 32(2):325-334.
102. ELTING LS, RUBENSTEIN EB, KURTIN D et al. : Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Cancer (1998) 83(12):2597-2607.
103. MACLAYTON DO, HALL RG II: Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. Ann. Pharmacother. (2007) 41(2):235-244.
104. DREW RH: Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections. Pharmacotherapy (2007) 27(2):227-249.
105. BUSH K, HEEP M, MACIELAG MJ, NOEL GJ: Anti-MRSA f}-lactams in development, with a focus on ceftobiprole: the fi rst anti-MRSA p-lactam to demonstrate clinical effi cacy. Expert Opin. Investig. Drugs (2007) 16(4):419-429.
106. MONGKOLRATTANOTHAI K, BOYLE S, KAHANA MD, DAUM RS: Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin. Infect. Dis. (2003) 37(8):1050-1058.
107. FRANCIS JS, DOHERTY MC, LOPATIN U et al : Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. (2005) 40(1):100-107.
108. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with infl uenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb. Mortal. Wkly Rep. (2007) 56(14):325-329.
109. CRAVEN DE, SHAPIRO DS: Staphylococcus aureus : times, they are a-changin'. Clin. Infect. Dis. (2006) 42(2):179-180.
110. OSTERHOLM MT: Preparing for the next pandemic. N. Engl. J. Med. (2005) 352(18): 1839-1842.